220 related articles for article (PubMed ID: 18834107)
1. Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.
Feng Y; Yin Y; Weiser A; Griffin E; Cameron MD; Lin L; Ruiz C; Schürer SC; Inoue T; Rao PV; Schröter T; Lograsso P
J Med Chem; 2008 Nov; 51(21):6642-5. PubMed ID: 18834107
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studies.
Hu Z; Wang C; Glunz PW; Li J; Cheadle NL; Chen AY; Chen XQ; Myers JE; Guarino VR; Rose A; Sack JS; Sitkoff D; Taylor DS; Xu S; Yan C; Zhang H; Zhang L; Hennan J; Adam LP; Wexler RR; Quan ML
Bioorg Med Chem Lett; 2020 Nov; 30(21):127495. PubMed ID: 32798651
[TBL] [Abstract][Full Text] [Related]
3. A review on ROCK-II inhibitors: From molecular modelling to synthesis.
Shah S; Savjani J
Bioorg Med Chem Lett; 2016 May; 26(10):2383-2391. PubMed ID: 27080184
[TBL] [Abstract][Full Text] [Related]
4. New thiazole carboxamides as potent inhibitors of Akt kinases.
Chang S; Zhang Z; Zhuang X; Luo J; Cao X; Li H; Tu Z; Lu X; Ren X; Ding K
Bioorg Med Chem Lett; 2012 Jan; 22(2):1208-12. PubMed ID: 22172705
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors.
Fang X; Yin Y; Chen YT; Yao L; Wang B; Cameron MD; Lin L; Khan S; Ruiz C; Schröter T; Grant W; Weiser A; Pocas J; Pachori A; Schürer S; Lograsso P; Feng Y
J Med Chem; 2010 Aug; 53(15):5727-37. PubMed ID: 20684608
[TBL] [Abstract][Full Text] [Related]
6. Hit to lead account of the discovery of bisbenzamide and related ureidobenzamide inhibitors of Rho kinase.
Morwick T; Büttner FH; Cywin CL; Dahmann G; Hickey E; Jakes S; Kaplita P; Kashem MA; Kerr S; Kugler S; Mao W; Marshall D; Paw Z; Shih CK; Wu F; Young E
J Med Chem; 2010 Jan; 53(2):759-77. PubMed ID: 20000469
[TBL] [Abstract][Full Text] [Related]
7. ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors.
Bandarage UK; Court J; Gao H; Nanthakumar S; Come JH; Giroux S; Green J
Bioorg Med Chem Lett; 2021 Feb; 33():127721. PubMed ID: 33259926
[TBL] [Abstract][Full Text] [Related]
8. Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidines.
Bosanac T; Hickey ER; Ginn J; Kashem M; Kerr S; Kugler S; Li X; Olague A; Schlyer S; Young ER
Bioorg Med Chem Lett; 2010 Jun; 20(12):3746-9. PubMed ID: 20471253
[TBL] [Abstract][Full Text] [Related]
9. Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account.
Wu F; Büttner FH; Chen R; Hickey E; Jakes S; Kaplita P; Kashem MA; Kerr S; Kugler S; Paw Z; Prokopowicz A; Shih CK; Snow R; Young E; Cywin CL
Bioorg Med Chem Lett; 2010 Jun; 20(11):3235-9. PubMed ID: 20462760
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 2 (JAK2).
Liu Q; Batt DG; Lippy JS; Surti N; Tebben AJ; Muckelbauer JK; Chen L; An Y; Chang C; Pokross M; Yang Z; Wang H; Burke JR; Carter PH; Tino JA
Bioorg Med Chem Lett; 2015 Oct; 25(19):4265-9. PubMed ID: 26320619
[TBL] [Abstract][Full Text] [Related]
11. Linking phenotype to kinase: identification of a novel benzoxaborole hinge-binding motif for kinase inhibition and development of high-potency rho kinase inhibitors.
Akama T; Dong C; Virtucio C; Sullivan D; Zhou Y; Zhang YK; Rock F; Freund Y; Liu L; Bu W; Wu A; Fan XQ; Jarnagin K
J Pharmacol Exp Ther; 2013 Dec; 347(3):615-25. PubMed ID: 24049062
[TBL] [Abstract][Full Text] [Related]
12. Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension.
Shaw D; Hollingworth G; Soldermann N; Sprague E; Schuler W; Vangrevelinghe E; Duggan N; Thomas M; Kosaka T; Waters N; van Eis MJ
Bioorg Med Chem Lett; 2014 Oct; 24(20):4812-7. PubMed ID: 25248678
[TBL] [Abstract][Full Text] [Related]
13. Detection of myosin light chain phosphorylation--a cell-based assay for screening Rho-kinase inhibitors.
Schröter T; Griffin E; Weiser A; Feng Y; LoGrasso P
Biochem Biophys Res Commun; 2008 Sep; 374(2):356-60. PubMed ID: 18638453
[TBL] [Abstract][Full Text] [Related]
14. Identification of 2-acylaminothiophene-3-carboxamides as potent inhibitors of FLT3.
Patch RJ; Baumann CA; Liu J; Gibbs AC; Ott H; Lattanze J; Player MR
Bioorg Med Chem Lett; 2006 Jun; 16(12):3282-6. PubMed ID: 16580199
[TBL] [Abstract][Full Text] [Related]
15. High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules.
Andrews PD; Becroft M; Aspegren A; Gilmour J; James MJ; McRae S; Kime R; Allcock RW; Abraham A; Jiang Z; Strehl R; Mountford JC; Milligan G; Houslay MD; Adams DR; Frearson JA
Biochem J; 2010 Nov; 432(1):21-33. PubMed ID: 20854259
[TBL] [Abstract][Full Text] [Related]
16. Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications.
Lim J; Altman MD; Baker J; Brubaker JD; Chen H; Chen Y; Kleinschek MA; Li C; Liu D; Maclean JK; Mulrooney EF; Presland J; Rakhilina L; Smith GF; Yang R
Bioorg Med Chem Lett; 2015 Nov; 25(22):5384-8. PubMed ID: 26403930
[TBL] [Abstract][Full Text] [Related]
17. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase.
Kast R; Schirok H; Figueroa-Pérez S; Mittendorf J; Gnoth MJ; Apeler H; Lenz J; Franz JK; Knorr A; Hütter J; Lobell M; Zimmermann K; Münter K; Augstein KH; Ehmke H; Stasch JP
Br J Pharmacol; 2007 Dec; 152(7):1070-80. PubMed ID: 17934515
[TBL] [Abstract][Full Text] [Related]
19. The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38alpha MAP kinase.
Down K; Bamborough P; Alder C; Campbell A; Christopher JA; Gerelle M; Ludbrook S; Mallett D; Mellor G; Miller DD; Pearson R; Ray K; Solanke Y; Somers D
Bioorg Med Chem Lett; 2010 Jul; 20(13):3936-40. PubMed ID: 20570148
[TBL] [Abstract][Full Text] [Related]
20. 3,5-Disubstituted-indole-7-carboxamides: the discovery of a novel series of potent, selective inhibitors of IKK-β.
Miller DD; Bamborough P; Christopher JA; Baldwin IR; Champigny AC; Cutler GJ; Kerns JK; Longstaff T; Mellor GW; Morey JV; Morse MA; Nie H; Rumsey WL; Taggart JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2255-8. PubMed ID: 21429745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]